What is cervical cancer?
According to the worldwide statistics,
| a woman dies of cervical cancer in every minutes* | |
| a woman is diagnosed with cervical cancer in every eight seconds# |
According to HKCaR’s statistics, cervical cancer is fourth most common cancer in women worldwide. From 2018, cervical cancer has caused over 2.7%+ of female cancer deaths. Studies states that over 90-91% cervical cancer are infected by HPV *.
More than 90-91% of cervical cancers are infected by HPV
The medical profession has confirmed that almost all cervical cancers (90-91%) are caused by persistent infection with Human Papillomavirus (HPV). Compared with low-risk HPV, persistent infection with high-risk HPV causes cervical cancers. The chance of causing cervical cancer is at least 30 times higher*. And 90% of cervical cancers are related to HPV 16, 18, 31, 33, 45, 52, 58 high-risk viruses.
| HPV vaccine contains HPV virus capsid protein L1, which is the main antigen and does not cause disease or cancer | |
| The vaccine can trigger the body to amalgate virus-like particles (VLP) to produce immune antibodies | |
| The antibodies acts as protection and increase the immunity against the HPV virus when one may be exposed to in the future |
Designed for people who are vaccinated against HPV
Scientific and accurate, measuring the level of antibodies in the blood
| The latest HPV antibody test covers all antibodies of the nine-valent HPV vaccine, including HPV6, 11, 16, 18, 31, 33, 45, 52, 58 under the principle of antibody antigen-specific binding | |
| According to the degree of antibody-antigen binding, you can accurately determine the level of 9 antibodies through quantitative experiments | |
| Inoculate HPV vaccine within the time specified by the manufacturer, corresponding HPV antibodies will be detectable after vaccination to ensure adequate protection |
Antibody level vary from person to person, double confirmation of vaccine efficiency
| Different people have different levels of antibodies to HPV vaccine | |
| Result being positive indicates the antibody level is strong enough for protection | |
| HPV antibody test can test the effectiveness of the vaccine |
Test Specifications
| Test Code | Methodology | Specimen Requirements | Turnaround Time |
|---|---|---|---|
| IH9 | ELISA | 3ml clotted-blood | 5 working days |
Frequently asked questions (FAQs)
A1 : After vaccination: You can test whether the vaccine is effective and to ensure adequate protection.
Vaccinated before: To detect whether the vaccine is still effective to provide protection.
A2 : Whether vaccinated with a 4-valent vaccine or a 9-valent vaccine, you can still take HPV9 antibody testing which can detect the antibodies within both vaccinations.
A3 : HPV vaccine for men can help prevent genital warts and anal cancer. Testing with antibodies will ensure that the vaccine is effective and that there is adequate antibody protection.
A4 : For patients who have been infected, certain levels of antibodies are produced in the body.
Studies have shown that patients who have been infected will have a booster response to the vaccine with at least 10 times more antibodies than before the vaccine.
Reference
- * http://globocan.iarc.fr/old/FactSheets/cancers/cervix-new.asp
- # https://www.analcancerfoundation.org/about-hpv/hpv-facts-and-figures/
- + https://www.chp.gov.hk/tc/healthtopics/content/25/56.html